Clinical Trials Logo

Movement Disorders clinical trials

View clinical trials related to Movement Disorders.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT00642057 No longer available - Clinical trials for Hyperkinetic Movement Disorders

Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements

TBZ
Start date: n/a
Phase:
Study type: Expanded Access

Although the results of studies looking at tetrabenazine have shown its effectiveness in the management of hyperkinetic(too much) movement disorders, it has not been made available in the U.S. The drug must be obtained from Cambridge Laboratories, the distributor, using an individual IND (#16,161). The cost of the drug is passed on to the patient. The purpose of the protocol is to provide an efficacious drug, with few side effects, in an attempt to get rid of a variety of incapacitating dyskinesias (abnormal movements).